美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Invesco Nasdaq Biotechnology ETF

34.69

-0.4365-1.24%

盤後：34.720.0307+0.09%16:15 EDT

成交量：2.55萬

成交額：88.51萬

市值：9,643.63萬

市盈率：- -

高：35.13

開：35.13

低：34.63

收：35.13

52周最高：36.84

52周最低：23.42

股本：278.00萬

流通股本：278.00萬

量比：1.14

換手率：0.92%

股息：0.26

股息率：0.74%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

安進-阿斯利康肺癌聯合用藥在後期臨床試驗中顯著提升生存率

2026國談第五日：商保創新藥目錄價格協商開始多家藥企攜核藥、CAR-T新藥等重磅藥物進場

2026國談第五日：商保創新藥目錄價格協商開始多家藥企攜核藥、CAR-T新藥等重磅藥物進場

市場風向標：安進股價遭受重創

市場消息：派拉蒙天空之舞採取措施防範延期產生的成本，華納兄弟探索併購交易即將完成。

Assembly Biosciences有望獲得高達2.8億美元里程碑付款及美國境外特許權使用費

Assembly Biosciences旗下Gs-1179預計2026年底前將推進至生殖器皰疹二期臨床試驗階段

Assembly Biosciences：吉利德獨享HSV HPI項目臨床開發與商業化權利

Assembly Biosciences行使與吉利德關於HSV解旋酶-引物酶抑制劑項目的美國利潤分成選擇權

安進股價或創二十餘年來最大單日跌幅

福泰製藥(VRTX)股票9月8日盤中下跌3.06%：投資者必看的核心信息

TradingKey中文

吉利德科學(GILD)股票9月8日盤中下跌3.26%：釋放什麼信號？

TradingKey中文

諾華公司一款降膽固醇藥物在臨床試驗中失敗，Royalty Pharma股價下跌

中藥創新從「經驗方」走到「數據方」

安進(AMGN)股票9月8日盤中下跌8.33%：真相來了

TradingKey中文

BUZZ——美國股市動態-Sigma Lithium、Shake Shack、諾華

更正-更新版 1-安進與阿斯利康的藥物組合在晚期研究中幫助肺癌患者延長了生存期

阿斯利康慢阻肺藥物兩項晚期臨床試驗取得成功

环球市场播报

安進股價下跌7%，創下自2025年6月以來最大單日跌幅。

DELPHI‑305 三期臨床試驗達到主要終點。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/IBBQ/news?page=8"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":34.6893,"timestamp":1789761600000,"preClose":35.1258,"halted":0,"volume":25482,"hourTrading":{"tag":"盘后","latestPrice":34.72,"preClose":34.6893,"latestTime":"16:15 EDT","volume":9,"amount":312.326514,"timestamp":1789762500328,"change":0.0307,"changeRate":0.000885,"amplitude":0.000885},"delay":0,"changeRate":-0.012426763233862154,"floatShares":2780001,"shares":2780001,"eps":0,"marketStatus":"盤後交易","change":-0.4365,"latestTime":"09-18 17:57:09 EDT","open":35.13,"high":35.13,"low":34.6296,"amount":885086,"amplitude":0.014246,"askPrice":52.1,"askSize":100,"bidPrice":32.86,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1789776000000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":35.1258,"sharesOutstanding":2520001,"nav":34.34966,"aum":95492089.14966,"dividendRate":0.007406,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":34.72,"preClose":34.6893,"latestTime":"16:15 EDT","volume":9,"amount":312.326514,"timestamp":1789762500328,"change":0.0307,"changeRate":0.000885,"amplitude":0.000885},"volumeRatio":1.139227,"impliedVol":0.0457,"impliedVolPercentile":0.0199},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":2780001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.139227,"shares":2780001,"dividePrice":0.2569,"high":35.13,"amplitude":0.014246,"preClose":35.1258,"low":34.6296,"week52Low":23.42,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":34.6893,"committee":0.333333,"eps":0,"divideRate":0.007406,"volume":25482,"delay":0,"ttmEps":0,"open":35.13,"prevYearClose":28.3962,"prevWeekClose":34.472,"prevMonthClose":35.4742,"prevQuarterClose":32.66,"fiveDayClose":34.472,"twentyDayClose":35.8,"sixtyDayClose":31.2119},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"IBBQ","amount":0.0287,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666309213","title":"安進-阿斯利康肺癌聯合用藥在後期臨床試驗中顯著提升生存率","url":"https://stock-news.laohu8.com/highlight/detail?id=2666309213","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666309213?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 10:39","pubTimestamp":1788921579,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4581","LU0109394709.USD","PJP","BK4566","LU0122379950.USD","BK4599","IE00B2B36J28.USD","LU1023059063.AUD","LU2112291526.USD","LU2242646821.SGD","BIB","LU1571399168.USD","LU2242652126.USD","BMED","LU2468319806.SGD","MDTX","IE0009355771.USD","IE00BJT1NW94.SGD","BK4533","IE00B4R5TH58.HKD","LU0889565916.HKD","BBH","BK4588","IBBJ","PSYK","LU0058720904.USD","SG9999001440.SGD","LU2089984988.USD","IBB","TBXU","BK4534","LU0289739699.SGD","IBBQ","LU0320765992.SGD","LU1057294990.SGD","LU0868494617.USD","IE00BFTCPJ56.SGD","LU1983299246.USD","BK4585","LU1061106388.HKD","AMGN","IE0002141913.USD","BK4139","PBE","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666305240","title":"2026國談第五日：商保創新藥目錄價格協商開始 多家藥企攜核藥、CAR-T新藥等重磅藥物進場","url":"https://stock-news.laohu8.com/highlight/detail?id=2666305240","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666305240?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 09:06","pubTimestamp":1788915970,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1574","LNGR","06978","159992","IBBQ","MEDX","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666303231","title":"2026國談第五日：商保創新藥目錄價格協商開始 多家藥企攜核藥、CAR-T新藥等重磅藥物進場","url":"https://stock-news.laohu8.com/highlight/detail?id=2666303231","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666303231?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 08:20","pubTimestamp":1788913212,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LNGR","IBBQ","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112638879","title":"市場風向標：安進股價遭受重創","url":"https://stock-news.laohu8.com/highlight/detail?id=1112638879","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112638879?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 05:35","pubTimestamp":1788903338,"startTime":"0","endTime":"0","summary":"“这对安进而言，堪称最糟糕的结局。”——巴克莱分析师艾米丽·菲尔德如此评价。此前，诺华制药公布了其心脏病药物令人失望的试验结果，这一披露不仅让诺华自身承压，更给安进旗下一款重磅药物蒙上了厚厚的阴影。","market":"us","thumbnail":"https://static.tigerbbs.com/e5b05f9c7e258c0791b0ff14e4bfadad","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e5b05f9c7e258c0791b0ff14e4bfadad"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","PBE","LU0868494617.USD","BK4533","BK4581","LU0320765992.SGD","LU2089984988.USD","BBH","AMGN","LU0889565916.HKD","LU2468319806.SGD","IE00B2B36J28.USD","PJP","LU1057294990.SGD","BK4599","IE0009355771.USD","LU0122379950.USD","LU0109394709.USD","IBB","BK4139","IE00BFTCPJ56.SGD","LU0289739699.SGD","LU1983299246.USD","IE00BJJMRZ35.SGD","LU2242652126.USD","LU2112291526.USD","LU1023059063.AUD","LU1061106388.HKD","SG9999001440.SGD","BK4566","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","BK4585","BK4534","LU0058720904.USD","BIB","LU2242646821.SGD","BK4588","IBBQ","IE0002141913.USD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370679","title":"市場消息：派拉蒙天空之舞採取措施防範延期產生的成本，華納兄弟探索併購交易即將完成。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370679","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370679?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 05:12","pubTimestamp":1788901933,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["TBXU","IEFN","ACTV","MNA","PEVC","CANC","DFMC","UYG","BK4588","IBBQ","VXF","GTPE","BK4561","TMED","BK4571","IYH","BK4108","PSP","MMID","RFG","AAUM","RSPH","WMG","XLFI","FFSM","PRVT","PBPH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136308873","title":"Assembly Biosciences有望獲得高達2.8億美元里程碑付款及美國境外特許權使用費","url":"https://stock-news.laohu8.com/highlight/detail?id=1136308873","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136308873?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 04:02","pubTimestamp":1788897732,"startTime":"0","endTime":"0","summary":"Assembly Biosciences公司日前披露，其在海外市场具备资格获取最高达2.8亿美元的里程碑款项，外加相应特许权使用费收入。据悉，这家生物科技企业所预期的资金流入将源自美国以外地区。对Assembly Biosciences而言，这笔潜在收入不仅反映其管线资产的外部合作价值，也可能为其后续研发投入提供坚实支撑。市场人士认为，此类非美国市场的收益结构有助于分散地域风险，增强公司财务韧性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","LU2468319806.SGD","IE00BSNM7G36.USD","LU0109394709.USD","LU2087621335.USD","IE00BKVL7J92.USD","LU1037948897.HKD","TMED","BK4550","LU1674673691.USD","LU1839511570.USD","LU0965509101.SGD","LU1430594728.SGD","LU0882574055.USD","TBXU","IE00BZ1G4Q59.USD","BK4532","LU1057294990.SGD","LU0965509010.AUD","BMED","LU0965509283.SGD","GILD","LU1674673428.USD","MEDI","LU1571399168.USD","IE00B19Z3B42.SGD","SG9999015945.SGD","LU1023059063.AUD","LU0058720904.USD","IBB","IE00B3T34201.USD","LU1778281490.HKD","LU1934455863.HKD","LU0823416689.USD","LU2112291526.USD","SG9999015978.USD","BK4568","LU0114720955.EUR","LU1934455194.USD","IBBQ","LU2324357040.USD","BK4566","IE00B19Z3581.USD","LU1066051498.USD","LU2089984988.USD","LU1934455277.USD","SG9999015986.USD","LU1037948541.HKD","LU0861579265.USD","LU0234570918.USD","BBH","LU0965508806.USD","LU1066053197.SGD","LU1585245621.USD","LU2357627491.SGD","SG9999015952.SGD","ASMB","LU0320765992.SGD","LU1061106388.HKD","BK4583","LU0859254822.USD","LU0889565916.HKD","LU0289739699.SGD","BIB","BK4139","IE0002270589.USD","IE00B7SZLL34.SGD","BK4578","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154623157","title":"Assembly Biosciences旗下Gs-1179預計2026年底前將推進至生殖器皰疹二期臨床試驗階段","url":"https://stock-news.laohu8.com/highlight/detail?id=1154623157","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154623157?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 04:02","pubTimestamp":1788897731,"startTime":"0","endTime":"0","summary":"Assembly Biosciences公司日前宣布，其研发管线中的候选药物Gs-1179有望在2026年年底之前顺利迈入针对生殖器疱疹的二期临床试验阶段。生殖器疱疹作为一种常见的性传播感染疾病，全球患者群体庞大，对创新疗法的需求十分迫切。Assembly Biosciences正积极加速该药物的研发进程，以期尽早为患者带来新的治疗选择。业内分析人士指出，若Gs-1179能够顺利通过后续试验的严格考验，将可能重塑该适应症的市场格局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0289739699.SGD","BBH","LU0122379950.USD","ASMB","IBB","BK4568","LU0882574055.USD","TMED","BK4566","SG9999015986.USD","LU1061106388.HKD","LU0109394709.USD","BK4585","BK4583","BK4578","GILD","LU0889565916.HKD","LU0114720955.EUR","BK4532","LU1674673428.USD","TBXU","LU0859254822.USD","LU2112291526.USD","SG9999015952.SGD","LU1778281490.HKD","LU1066053197.SGD","LU1023059063.AUD","LU1430594728.SGD","LU2089984988.USD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","LU2324357040.USD","LU0965509010.AUD","LU1934455863.HKD","IE00BKVL7J92.USD","BIB","LU0965509101.SGD","LU1037948897.HKD","LU1674673691.USD","LU2087621335.USD","LU2357627491.SGD","LU1585245621.USD","LU1934455277.USD","LU2468319806.SGD","IBBQ","LU0861579265.USD","LU0058720904.USD","LU1037948541.HKD","LU1839511570.USD","MEDI","BMED","BK4139","SG9999015945.SGD","LU1057294990.SGD","LU0965509283.SGD","LU1066051498.USD","LU1571399168.USD","LU0234570918.USD","LU0965508806.USD","BK4550","LU0320765992.SGD","SG9999015978.USD","LU0823416689.USD","LU1934455194.USD","IE00B3T34201.USD","IE0002270589.USD","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115029168","title":"Assembly Biosciences：吉利德獨享HSV HPI項目臨床開發與商業化權利","url":"https://stock-news.laohu8.com/highlight/detail?id=1115029168","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115029168?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 04:01","pubTimestamp":1788897702,"startTime":"0","endTime":"0","summary":"Assembly Biosciences宣布，吉利德科学已保留其HSV HPI项目的独家临床开发及商业化权利。这一决定标志着双方合作进一步深化，吉利德将全权主导该项目的后续推进与市场布局。对于Assembly Biosciences而言，此举不仅明确了合作伙伴的战略优先级，也为其自身聚焦其他管线资源提供了更大灵活性。业内观察人士指出，HSV HPI项目的独家授权，反映了吉利德在抗病毒治疗领域持续加码的雄心，同时也凸显了该类创新疗法在未被满足的医疗需求中所蕴含的巨大潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509283.SGD","BBH","BK4578","LU0114720955.EUR","LU0823416689.USD","IE00B19Z3581.USD","LU0861579265.USD","LU0889565916.HKD","LU1066053197.SGD","LU1430594728.SGD","LU1571399168.USD","SG9999015986.USD","LU0320765992.SGD","BK4583","LU1674673691.USD","LU1061106388.HKD","IE00BZ1G4Q59.USD","LU1934455863.HKD","LU2089984988.USD","LU1023059063.AUD","MEDI","LU0965508806.USD","LU0122379950.USD","ASMB","LU2324357040.USD","LU2357627491.SGD","TMED","LU0109394709.USD","IBB","LU1674673428.USD","LU1037948541.HKD","GILD","BMED","SG9999015952.SGD","IE00B7SZLL34.SGD","LU2468319806.SGD","LU1066051498.USD","IE0002270589.USD","LU0882574055.USD","LU1037948897.HKD","LU0859254822.USD","IBBQ","LU1839511570.USD","BK4568","IE00BSNM7G36.USD","LU1057294990.SGD","LU2112291526.USD","IE00B19Z3B42.SGD","BK4532","LU0965509010.AUD","BK4139","BK4585","BK4588","IE00B3T34201.USD","BIB","LU0058720904.USD","BK4550","LU0289739699.SGD","LU1934455194.USD","LU1934455277.USD","SG9999015945.SGD","BK4566","IE00BKVL7J92.USD","LU0965509101.SGD","LU2087621335.USD","SG9999015978.USD","LU1585245621.USD","TBXU","LU0234570918.USD","LU1778281490.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179230759","title":"Assembly Biosciences行使與吉利德關於HSV解旋酶-引物酶抑制劑項目的美國利潤分成選擇權","url":"https://stock-news.laohu8.com/highlight/detail?id=1179230759","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179230759?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 04:01","pubTimestamp":1788897669,"startTime":"0","endTime":"0","summary":"Assembly Biosciences公司已正式行使与吉利德科学就HSV解旋酶-引物酶抑制剂项目达成的美国利润分成选择权。这一战略举措标志着双方合作进入新阶段，有望加速该抗病毒疗法的临床开发与商业化进程。通过行使该选择权，Assembly Biosciences将能够分享该药物在美国市场的未来收益，同时借助吉利德在抗病毒领域的深厚积累与市场渠道，共同推进这一潜在重磅药物的落地。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015978.USD","LU1066051498.USD","GILD","LU1934455863.HKD","LU0122379950.USD","LU0965509101.SGD","LU0289739699.SGD","LU1778281490.HKD","BMED","IBB","SG9999015945.SGD","SG9999015952.SGD","BK4583","LU0859254822.USD","LU0109394709.USD","BK4578","BK4550","IE00B19Z3581.USD","BK4588","LU2468319806.SGD","LU0965509283.SGD","IE0002270589.USD","IBBQ","LU0861579265.USD","LU0234570918.USD","LU0823416689.USD","LU2357627491.SGD","LU0965508806.USD","LU1571399168.USD","LU2089984988.USD","LU1674673428.USD","IE00B7SZLL34.SGD","IE00BZ1G4Q59.USD","LU0058720904.USD","LU1585245621.USD","LU1674673691.USD","TBXU","LU1037948541.HKD","BK4585","LU1839511570.USD","LU2112291526.USD","LU1430594728.SGD","LU1037948897.HKD","LU2087621335.USD","LU1066053197.SGD","LU0114720955.EUR","TMED","LU0320765992.SGD","BK4532","BIB","IE00BSNM7G36.USD","IE00BKVL7J92.USD","LU0882574055.USD","IE00B3T34201.USD","SG9999015986.USD","MEDI","BK4568","BK4566","LU2324357040.USD","ASMB","LU1061106388.HKD","LU1934455277.USD","LU1057294990.SGD","BBH","LU1023059063.AUD","LU0889565916.HKD","LU1934455194.USD","LU0965509010.AUD","IE00B19Z3B42.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111756325","title":"安進股價或創二十餘年來最大單日跌幅","url":"https://stock-news.laohu8.com/highlight/detail?id=1111756325","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111756325?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 02:23","pubTimestamp":1788891793,"startTime":"0","endTime":"0","summary":"安进公司股价近期重挫逾9%，这一跌幅令这家生物技术巨头有望迎来自2000年10月以来最惨淡的单日表现。此番暴跌的导火索，源于诺华制药宣布其心脏病药物pelacarsen在降低心血管事件风险方面未能优于安慰剂，试验宣告失败。周二，礼来股价小幅下挫1.9%。安进的跌势因BMO资本市场的下调评级而进一步加剧，使其沦为标普500指数和纳斯达克100指数中的最大输家。","market":"hk","thumbnail":"https://static.tigerbbs.com/95977f976807e41662cc4b3ba02269af","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/95977f976807e41662cc4b3ba02269af"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","LU1983299246.USD","BK4581","IE00BJJMRZ35.SGD","IBBQ","BIB","BK4534","BK4588","BK4566","LU2242646821.SGD","LU1571399168.USD","IE00B2B36J28.USD","LU0868494617.USD","LU0320765992.SGD","LU2089984988.USD","LU0889565916.HKD","IE0009355771.USD","BK4139","AMGN","IE00B4R5TH58.HKD","LU2112291526.USD","LU1061106388.HKD","LU0109394709.USD","LU0122379950.USD","PBE","BBH","LU1023059063.AUD","LU0058720904.USD","04332","LU2242652126.USD","IE00BFTCPJ56.SGD","SG9999001440.SGD","TBXU","LU0289739699.SGD","IE00BJT1NW94.SGD","PJP","LU1057294990.SGD","BK4585","BK4533","IE0002141913.USD","BK4599","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374214","title":"福泰製藥(VRTX)股票9月8日盤中下跌3.06%：投資者必看的核心信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374214","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666374214?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 02:16","pubTimestamp":1788891392,"startTime":"0","endTime":"0","summary":"• Vertex 股价在反弹至接近52周高点后遭遇波动与获利回吐。\n• 对 Crinetics 的收购整合要到2029年才能实现非GAAP增盈。\n• 技术指标显示 MACD 呈中性，RSI 呈中性，威廉指标（Williams %R）呈超卖状态。","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262156640-market-movers-vrtx-20260908","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0256863811.USD","LU2362541273.HKD","IE00B894F039.SGD","LU2362540622.SGD","LU0079474960.USD","IE0002270589.USD","IE00B19Z3581.USD","IBBQ","LU1069344957.HKD","LU0289739699.SGD","LU2089984988.USD","BK4139","LU1674673428.USD","LU1778281490.HKD","SG9999001176.SGD","BK4532","LU1430594728.SGD","BBH","LU0432979614.USD","IE0002141913.USD","TBXU","LU2362541513.USD","BK4588","LU1093756168.USD","IE0009355771.USD","IDNA","SG9999001176.USD","LU0417517546.SGD","LU1585245621.USD","LU1093756325.SGD","LU1674673691.USD","SGXZ57979304.SGD","LU0889565916.HKD","BK4585","SG9999013999.USD","LU0234570918.USD","LU2417539215.USD","IE00B19Z9Z06.USD","VRTX","LU1035775433.USD","PBE","LU0061475181.USD","GNMX","BK4533","IE00B2B36J28.USD","BIB","IBB","IE00BJT1NW94.SGD","LU2237438978.USD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374570","title":"吉利德科學(GILD)股票9月8日盤中下跌3.26%：釋放什麼信號？","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374570","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666374570?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 01:16","pubTimestamp":1788887780,"startTime":"0","endTime":"0","summary":"• 吉利德在经历了长达数月的持续上涨后，因获利回吐而出现回调。\n• 强劲的第二季度营收主要受其旗舰 HIV 和 Trodelvy 产品线的推动。\n• 分析师维持“买入”评级，平均目标价为 157.79 美元。","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262156554-market-movers-gild-20260908","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","LU2087621335.USD","BK4532","LU0861579265.USD","MEDI","TBXU","IE00B19Z3581.USD","LU1037948541.HKD","BK4568","BIB","IE00BSNM7G36.USD","LU1571399168.USD","LU0965508806.USD","LU0289739699.SGD","SG9999015986.USD","IBB","LU0965509101.SGD","BK4583","IE00BKVL7J92.USD","LU0114720955.EUR","LU0122379950.USD","IE00B3T34201.USD","TMED","SG9999015952.SGD","IE00BZ1G4Q59.USD","LU1674673691.USD","IBBQ","BMED","SG9999015945.SGD","LU0058720904.USD","LU0109394709.USD","LU1934455277.USD","SG9999015978.USD","BK4578","LU0320765992.SGD","LU1023059063.AUD","LU1674673428.USD","LU0882574055.USD","IE0002270589.USD","LU2324357040.USD","IE00B7SZLL34.SGD","LU2112291526.USD","LU0859254822.USD","GILD","LU0823416689.USD","LU1839511570.USD","BBH","BK4585","LU1778281490.HKD","LU1430594728.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666371445","title":"諾華公司一款降膽固醇藥物在臨床試驗中失敗，Royalty Pharma股價下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2666371445","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666371445?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 00:41","pubTimestamp":1788885660,"startTime":"0","endTime":"0","summary":"——Royalty Pharma** RPRX重申“其2030年投资组合收入目标为47亿美元或更高”** 计入本交易日涨幅，该股今年以来累计上涨54.7%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4T4501DE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","BK4533","BK4581","IE00B2B36J28.USD","LU1983299246.USD","LU1023059063.AUD","IE00B4R5TH58.HKD","IE0002141913.USD","IHE","LU2112291526.USD","AMGN","LU1057294990.SGD","IBBQ","LU2242652126.USD","LU0109394709.USD","LU0889565916.HKD","LU1571399168.USD","BK4139","RPRX","SG9999001440.SGD","IBB","TBXU","LU0058720904.USD","LU0320765992.SGD","BK4566","BBH","IE00BJJMRZ35.SGD","BK4588","PBE","BK4599","BK4007","LU1061106388.HKD","PJP","BK4534","LU2242646821.SGD","BIB","BK4585","IE00BJT1NW94.SGD","LU2089984988.USD","LU0868494617.USD","LU0289739699.SGD","LU0122379950.USD","LU2468319806.SGD","IONS","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666654371","title":"中藥創新從「經驗方」走到「數據方」","url":"https://stock-news.laohu8.com/highlight/detail?id=2666654371","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666654371?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 23:28","pubTimestamp":1788881280,"startTime":"0","endTime":"0","summary":"传统中药源于历代医家的经验积累，但面对现代医学的检验标准，如何用可重复、可量化的数据证明其安全性和有效性，始终是中药现代化进程中绕不开的一道题。近期，《证券日报》记者在梳理相关上市公司公告时注意到，有一个词被越来越多的中药企业频繁提及——循证医学。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609083868422064.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609083868422064.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LNGR","06978","RCT","IBBQ","BK4159","BK1161","MEDX","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665376637","title":"安進(AMGN)股票9月8日盤中下跌8.33%：真相來了","url":"https://stock-news.laohu8.com/highlight/detail?id=2665376637","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665376637?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 22:16","pubTimestamp":1788876978,"startTime":"0","endTime":"0","summary":"• 诺华 pelacarsen 试验失败，加大了安进竞品 olpasiran 的临床不确定性。\n• 出于对估值的担忧，BMO Capital 将安进的评级从“跑赢大盘”下调至“与大盘持平”。\n• 技术指标显示，安进的 RSI 为 40.256，威廉指标（Williams %R）为 97.857。","market":"other","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262156239-market-movers-amgn-20260908","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","BK4585","LU0109394709.USD","BBH","AMGN","BK4533","LU2242646821.SGD","LU1983299246.USD","BK4599","IE0002141913.USD","BK4139","LU0320765992.SGD","LU1061106388.HKD","IE00BJJMRZ35.SGD","BK4581","IE0009355771.USD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","LU1571399168.USD","LU2112291526.USD","PJP","BK4588","IBB","LU0868494617.USD","BK4566","LU2242652126.USD","IBBQ","LU0289739699.SGD","LU0122379950.USD","LU1057294990.SGD","IE00B2B36J28.USD","BIB","LU0058720904.USD","LU2089984988.USD","LU2468319806.SGD","LU1023059063.AUD","BK4534","PBE","LU0889565916.HKD","IE00BFTCPJ56.SGD","SG9999001440.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665375206","title":"BUZZ——美國股市動態-Sigma Lithium、Shake Shack、諾華","url":"https://stock-news.laohu8.com/highlight/detail?id=2665375206","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665375206?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:58","pubTimestamp":1788875887,"startTime":"0","endTime":"0","summary":"BUZZ——美国股市动态-Sigma Lithium、Shake Shack、诺华工作区中用于查询单只股票行情的搜索字符串：STXBZ《今日展望》通讯：https://refini.tv/3LI4BU7《晨间新闻简报》：https://refini.tv/3dKUyB8路透9月8日-周二开盘时，华尔街主要股指涨跌不一，中东地区新一轮冲突推动油价升至7月下旬以来的最高水平，而市场正在等待本周晚些时候","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4S45014M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2265009873.SGD","LU1878469433.USD","BK4120","IE0031619046.USD","GNOM","LU0950375773.USD","SGML","BK4585","LU2362541513.USD","LU0114720955.EUR","LU0878866978.SGD","ABM","LU1989764664.SGD","IONS","IONZ","IONL","RGTC","SG9999001440.SGD","IE00BFTCPJ56.SGD","LU0882574055.USD","BK4535","IBAT","PHVS","LU2491050071.SGD","IE00B19Z4B17.USD","LU1057294990.SGD","LU2112291526.USD","IE00BLSP4239.USD","CTEC","LU2491049909.HKD","BK4534","BK4591","RGTX","LU0251132253.USD","SEI","HYDR","BK4007","LU2506951792.HKD","IE00B4R5TH58.HKD","LU0170899867.USD","RGTI","LU0234572021.USD","LU2362541273.HKD","BK4556","BEX","LU2506952097.USD","LU2506952170.USD","BSX","BK4581","BK4592","IE00BBT3K403.USD","RGTZ","BK4139","BK4602","IONQ","LU0985489474.SGD","BK4141","LU0444971666.USD","LU0211331839.USD","SGXZ57979304.SGD","BE","LU2468319806.SGD","RGYY","SHAK","LU0433182093.SGD","LU0985481810.HKD","SG9999013999.USD","TBXU","LU0068578508.USD","BK4102","BK4131","ILMN","LU0187121727.USD","IE0009354923.USD","LU0320765489.SGD","ICLN","BK4168","LU0353189763.USD","IE00BLSP4452.SGD","LU1791710582.SGD","BK4504","LU0238689110.USD","LU0823416689.USD","XES","UPGR","BK4082","VTWG","IE0002141913.USD","04332","PFE","CNRG","IE000M9KFDE8.USD","LU1153585028.USD","BIB","LU2506951875.HKD","ZAP","LU0138981039.USD","LU0077335932.USD","BK4550","LU1642822529.SGD","IE00B19Z3B42.SGD","LU0306807586.USD","LU1791710400.SGD","LU1066051498.USD","LU1883839398.USD","LU2244417387.USD","ROIV","IE0009355771.USD","LU1983299246.USD","LU0266013472.USD","LU1989764748.USD","LU0321505439.SGD","LU0289739699.SGD","LU0868494617.USD","LU0444973449.USD","QTUP","BK4541","WATS","BK4532","LU0011850046.USD","LU2506951958.HKD","LU0029874061.USD","BK4182","LU2357305700.SGD","LU2324357040.USD","SG9999002232.USD","WQTM","LU0122379950.USD","LU0320765992.SGD","OIH","LU0823414478.USD","LU1988902786.USD","LU2294711713.HKD","CHRW","LU0528227936.USD","SMOG","LU0321505868.SGD","LU0225771236.USD","SRPU","IE0002270589.USD","IE00BJJMRZ35.SGD","AMGN","BEG","IE00B66KJ199.SGD","LU2098885051.SGD","BK4209","LU1989772840.SGD","LU0823417653.USD","USNG","LU0306806265.USD","IBB","LU0267386448.USD","LU1720051108.HKD","LU1093756325.SGD","LU2242649171.HKD","LU1489326972.SGD","LU2264538146.SGD","LU2543165471.USD","NVS","SG9999001176.USD","LU0476273544.USD","SRPT","LU0225284248.USD","LU2089984988.USD","IE00BJT1NW94.SGD","IE0034235188.USD","CQTM","LU1291159041.SGD","SIMS","BK4597","IE00B19Z3581.USD","BK4567","IE00B2B36J28.USD","LU1894683264.USD","LU1061106388.HKD","LU1366192091.USD","LU2491050154.USD","SG9999002224.SGD","FRNW","LU2362540622.SGD","BK4505","LU0058720904.USD","LU2249611893.SGD","IE00B3T34201.USD","BK4121","LU0353189680.USD","PTH","BK4124","UNFI","BK4548","LU1023059063.AUD","NTLA","LU0432979614.USD","BK4179","LU1066053197.SGD","LU1571399168.USD","BK4170","IONC","LU1804176565.USD","BHVN","LU0957808578.USD","LU0225283273.USD","LU2357125470.USD","LU0208291251.USD","BEC","BK4533","SG9999011175.SGD","LU0048584097.USD","BBH","GNMX","IE00B7SZL793.SGD","LU1548497426.USD","IONX","LU2242646821.SGD","ALV","MEDX","LU0456855351.SGD","LU1064131342.USD","OZEM","RGTU","LU1303367103.USD","LU1720051017.SGD","BK4599","SG9999001176.SGD","DYN","PBE","BK4588","LU2596442595.SGD","PPH","PJP","LU1718418525.SGD","LU0345769631.USD","IOYY","SG9999003800.SGD","LU1093756168.USD","LU0070302665.USD","LU1989772923.USD","BEZ","BK4566","LU0109394709.USD","LU0823417737.USD","LU1894683348.USD","LU0128526141.USD","LU0823414551.USD","LU2087625088.SGD","LU1815336760.USD","LU1861558580.USD","LU1989771016.USD","VCLN","LU2242652126.USD","BK4578","EGGY","IBBQ","LU0889565916.HKD","LU1861559042.SGD","LU0345769128.USD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665251375","title":"更正-更新版 1-安進與阿斯利康的藥物組合在晚期研究中幫助肺癌患者延長了生存期","url":"https://stock-news.laohu8.com/highlight/detail?id=2665251375","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665251375?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:52","pubTimestamp":1788875520,"startTime":"0","endTime":"0","summary":"更新版 1-阿斯利康的联合用药方案在晚期研究中帮助肺癌患者延长了生存期全文补充了有关临床试验和背景的详细信息路透9月8日-阿斯利康AZN.L周二表示，其抗癌药物Imfinzi与安进的AMGN.O靶向免疫疗法Imdelltra联合使用，在一项晚期临床试验中显著提高了广泛期小细胞肺癌患者的总生存期。癌症治疗药物占阿斯利康销售额近一半；2025年，在该公司256.2亿美元的肿瘤产品收入中，Imfinzi贡献了60.6亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4T45013T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930490.SGD","PJP","LU0557290698.USD","LU0708994859.HKD","LU2237443622.USD","LU0887340254.USD","AMGN","LU0969580561.USD","LU2242646821.SGD","LU2468319806.SGD","IBB","03165","LU0997586432.USD","LU1153585028.USD","BBH","LU2089284900.SGD","LU0029864427.USD","LU1989771016.USD","AZN.UK","LU0058720904.USD","LU0553294199.USD","LU0889566641.SGD","LU0738911758.USD","PBE","LU1046234339.USD","LU0158827948.USD","LU1273509221.SGD","IE00B3T34201.USD","LU0171293334.USD","LU0784384876.USD","LU1196032939.SGD","LU0289739699.SGD","LU0211328371.USD","BK4585","LU0823416689.USD","LU1267930227.SGD","LU0211327993.USD","LU2108987350.USD","TBXU","LU2125909593.SGD","LU0211326755.USD","LU0792757196.USD","BK4588","BK4533","LU2237443382.USD","LU1267930813.SGD","LU2279689827.SGD","IE0009355771.USD","IBBQ","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665754133","title":"阿斯利康慢阻肺藥物兩項晚期臨床試驗取得成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2665754133","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665754133?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:45","pubTimestamp":1788875100,"startTime":"0","endTime":"0","summary":"阿斯利康周二公布慢阻肺在研药物两项成功的晚期临床试验完整结果，市场对该药创造数十亿美元营收的预期进一步升温。据阿斯利康数据，美国确诊及未确诊慢阻肺患者合计约 1600 万2600 万人，慢阻肺位列美国第五大死亡原因。阿斯利康近期将该药物销售峰值预期上调至50 亿美元以上，助力公司冲刺 2030 年整体 800 亿美元营收目标。两项临床试验同时纳入现吸烟者、既往吸烟者，覆盖全部嗜酸粒细胞水平、全部肺功能严重程度分级的患者。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-09-08/doc-inircrns9296776.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["PSYK","BMED","MDTX","IBBJ","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665375527","title":"安進股價下跌7%，創下自2025年6月以來最大單日跌幅。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665375527","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665375527?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:30","pubTimestamp":1788874246,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1057294990.SGD","BK4139","LU1983299246.USD","BK4566","IE0009355771.USD","AMGN","BBH","BK4588","LU0868494617.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU0122379950.USD","PJP","IE0002141913.USD","PBE","LU1023059063.AUD","LU0889565916.HKD","IE00B2B36J28.USD","BK4581","BK4533","LU0109394709.USD","LU2089984988.USD","LU2112291526.USD","LU0289739699.SGD","LU2242652126.USD","LU2242646821.SGD","SG9999001440.SGD","BK4599","LU0320765992.SGD","LU1571399168.USD","IBBQ","TBXU","BIB","BK4534","LU0058720904.USD","BK4585","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","IBB","LU1061106388.HKD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665373053","title":"DELPHI‑305 三期臨床試驗達到主要終點。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665373053","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665373053?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:19","pubTimestamp":1788873564,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MDTX","BMED","PSYK","IBBJ","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":8,"totalSize":215,"code":"91000000","status":"200"}]}}